Skip to main content
Day.News — Local News. Real Community.
CLANCY DAY NEWS
Local News. Real Community.

Health & Wellness

06/13/2026 · Clancy

Full Edition

Cambridge Scientists Test First AI-Designed Vaccine in Human Trial

Scientists at Cambridge University have conducted the first human trial of a vaccine designed by artificial intelligence. The AI-created vaccine aims to protect against multiple related viruses rather than a single pathogen.

06/13/2026
Read Story
Health

Remote workers show higher rates of depression and anxiety, study finds

A study in the journal Science found that remote workers reported more depression, anxiety, and visits to mental health professionals than workers in jobs requiring on-site presence. Researchers said the findings do not support forcing all employees back to offices.

06/13/2026

Health

CDC investigates Listeria outbreak connected to soft ricotta and requesón cheese

The Centers for Disease Control and Prevention is investigating a Listeria outbreak tied to soft ricotta and requesón cheese products. The agency has identified multiple cases across several states and recommends consumers check their refrigerators for affected items.

06/13/2026

Health

Ebola vaccine gap widens as Congo outbreak spreads without approved treatment

Health authorities have an effective Ebola vaccine, but it does not protect against the strain circulating in the Democratic Republic of Congo. Researchers are testing several vaccine candidates to address the outbreak.

06/13/2026

Health

Some Jurisdictions Curtail Public Health Powers Following Pandemic Disputes

Several jurisdictions have restricted the powers of their public health agencies following backlash over pandemic-era policies. The changes come amid ongoing debates over lockdowns, mask mandates, and vaccine requirements.

06/13/2026

Health

Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease

Researchers presenting findings from the FLOW trial at the 63rd European Renal Association Congress reported that weekly semaglutide injections improved health-related quality of life measures among adults with diabetes and kidney disease.

06/13/2026

Advertisement

Advertisement